Monographie - Aflibercept - Stabilis 4.0

Ultimele actualizari :
08/05/2024

Citostatic

Aflibercept

Injectabil

Stabilitatea in solutie

Stabilitatea in amestec

Factorii care influenteaza stabilitatea

Compatibilitate

Microunde

Bibliografie

Pdf

Denumirea comerciala

Denumirea comerciala

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Zaltrap	Belgia, Brazilia, Canada, Chilli, Danemarca, Ecuador, Elvetia, Finlanda, Franta, Germania, Irlanda, Islanda, Italia, Luxemburg, Marea Britanie, Norvegia, Peru, Romania, Slovenia, Spania, SUA, Suedia, Turcia, Ungaria
Zaltrapziv	Mexic

Bibliografie

Injectabil

Bibliografie : Aflibercept

	Tip	Publicare
3508	Laborator	Aflibercept (Zaltrap®) - Summary of Product characteristics Sanofi Aventis Group 2013
4728	Ziar	Hermosilla J, Pérez-Robles R, Salmerón-García A, Casares S, Cabeza J, Navas N. Stability study over time of clinical solutions of ziv-aflibercept prepared in infusion bags using a proper combination of physicochemical and functional strategies. J Pharm Biomed Anal 2021 ; 203:114209.
4798	Ziar	Gjølberg T, Lode H, Melo G, Mester S,Probst C, Sivertsen M, Jørstad ø, Andersen J, Moe M. A silicone Oil-Free Syringe Tailored for Intravitreal Injection of Biologics. Frontiers in Ophthalmology 2022 ;2

Mentions Légales